As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Aims and scope
The Journal of Ophthalmic Inflammation and Infection is a peer-reviewed open access journal published under the brand SpringerOpen. It presents current clinical and experimental research on a range of ophthalmic inflammation and infection topics.
Coverage includes original studies, review articles, brief reports, case reports, photo essays, and expert commentary on challenging cases. The journal reflects geographical variations in incidence of diseases as well as different treatment modalities worldwide.
This is the official journal of the International Ocular Inflammation Society (IOIS), and the editorial board includes international experts in the field of ophthalmic inflammation and infection.
Journal of Ophthalmic Inflammation and Infection is published in cooperation with the International Ocular Inflammation Society. Members of the Society will receive a full waiver on the article-processing charge for articles they publish in Journal of Ophthalmic Inflammation and Infection. Please request the discount code by contacting the Society.
Annual Journal Metrics
79 days to first decision for reviewed manuscripts only
75 days to first decision for all manuscripts
120 days from submission to acceptance
19 days from acceptance to publication
1.096 - Source Normalized Impact per Paper (SNIP)
0.477 - SCImago Journal Rank (SJR)
2.400 - CiteScore
9 Altmetric Mentions
- ISSN: 1869-5760 (electronic)